Savara (SVRA) Operating Expenses (2010 - 2026)
Savara's (SVRA) quarterly Operating Expenses came in at $39.0 million in Q1 2026, up 37.12% year-on-year from $28.4 million in Q1 2025, and up 16.67% on a QoQ basis from $33.4 million in Q4 2025.
Savara (SVRA) Operating Expenses (2010 - 2026) Analysis & Trends
Savara (SVRA) has 17 years of Operating Expenses data on file, last reported at $39.0 million in Q1 2026.
- On a quarterly basis, Operating Expenses rose 37.12% year-over-year to $39.0 million in Q1 2026; TTM through Mar 2026 was $134.1 million, a 22.86% increase from a year earlier, with the FY2025 full-year figure at $123.5 million, up 19.72% from the prior year.
- Operating Expenses for Q1 2026 stood at $39.0 million, up from $33.4 million in the prior quarter.
- Over the last five years, Operating Expenses for SVRA reached as high as $39.0 million in Q1 2026 and fell as low as $8.0 million in Q1 2022.
- Historically, Operating Expenses has averaged $21.4 million across 5 years, with a median of $22.5 million in 2024.
- Across the five-year window, Operating Expenses dropped 22.74% in 2022 and soared 89.76% in 2024, its largest moves.
- Year by year, Operating Expenses stood at $10.9 million in 2022, then soared by 62.11% to $17.6 million in 2023, then soared by 76.82% to $31.2 million in 2024, then increased by 7.2% to $33.4 million in 2025, then increased by 16.67% to $39.0 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $39.0 million in Q1 2026, $33.4 million in Q4 2025, and $30.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.10 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.78 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 445.22 Mn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 38.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.99 Mn |
| Dec 31, 2025 | 33.42 Mn |
| Sep 30, 2025 | 30.26 Mn |
| Jun 30, 2025 | 31.44 Mn |
| Mar 31, 2025 | 28.44 Mn |
| Dec 31, 2024 | 31.17 Mn |
| Sep 30, 2024 | 26.36 Mn |
| Jun 30, 2024 | 23.19 Mn |
| Mar 31, 2024 | 22.48 Mn |
| Dec 31, 2023 | 17.63 Mn |
| Sep 30, 2023 | 18.04 Mn |
| Jun 30, 2023 | 12.22 Mn |
| Mar 31, 2023 | 12.11 Mn |
| Dec 31, 2022 | 10.88 Mn |
| Sep 30, 2022 | 10.54 Mn |
| Jun 30, 2022 | 9.38 Mn |
| Mar 31, 2022 | 8.05 Mn |
| Dec 31, 2021 | 10.64 Mn |
| Sep 30, 2021 | 9.97 Mn |
| Jun 30, 2021 | 10.45 Mn |